Prevalence of Toxoplasma gondii and Toxocara canis among Patients with Uveitis

References

• Hwang DK, Chou YJ, Pu CY, et al. Epidemiology of uveitis among the Chinese population in Taiwan: a population-based study. Ophthalmology. 2012;119:2371–2376
   PubMed Web of Science ®Google Scholar
• Soheilian M, Heidari K, Yazdani S, et al. Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm. 2004;12:297–310
   PubMed Web of Science ®Google Scholar
• Em D. Focal points: clinical modules for ophthalmologists. In Ocular Toxoplasmosis: Clinical Presentation, Diagnosis and Therapy. San Francisco: American Academy of Ophthalmology; 1999
   Google Scholar
• McCannel CA, Holland GN, Helm CJ, et al. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol. 1996;121:35–46
   PubMed Web of Science ®Google Scholar
• Stewart JM, Cubillan LD, Cunningham ET Jr. Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina. 2005;25:1005–1013
   PubMed Web of Science ®Google Scholar
• Kijlstra A, Eissen OA, Cornelissen J, et al. Toxoplasma gondii infection in animal-friendly pig production systems. Invest Ophthalmol Vis Sci. 2004;45:3165–3169
   PubMed Web of Science ®Google Scholar
• Rothova A, de Boer JH, Ten Dam-van Loon NH, et al. Usefulness of aqueous humor analysis for the diagnosis of posterior uveitis. Ophthalmology. 2008;115:306–311
   PubMed Web of Science ®Google Scholar
• Westeneng AC, Rothova A, de Boer JH, et al. Infectious uveitis in immunocompromised patients and the diagnostic value of polymerase chain reaction and Goldmann-Witmer coefficient in aqueous analysis. Am J Ophthalmol. 2007;144:781–785
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global tuberculosis control: surveillance, planning, financing: WHO Report 2011
   Google Scholar
• Candolfi E, Pastor R, Huber R, et al. IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women. Diagn Microbiol Infect Dis. 2007;58:83–88
   PubMed Web of Science ®Google Scholar
• Gallian P CP, Bellafronte M-H, Dallibert C, Zappitelli P-P, De Micro P. Evaluation de l'automate complet EVOLIS (Bio-Rad) dans un contexte transfusionnel: aspects organisationnels et sécuritaires. La Gazette de la Transfusion n° 2003
   Google Scholar
• Griffais R, Andre PM, Thibon M. K-tuple frequency in the human genome and polymerase chain reaction. Nucleic Acids Res. 1991;19:3887–3891
   PubMed Web of Science ®Google Scholar
• Borecka A, Gawor J. Modification of gDNA extraction from soil for PCR designed for the routine examination of soil samples contaminated with Toxocara spp. eggs. J Helminthol. 2008;82:119–122
   PubMedGoogle Scholar
• Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80:844–848
   PubMed Web of Science ®Google Scholar
• Ohguro N, Sonoda KH, Takeuchi M, et al. The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol. 2012;56:432–435
   PubMed Web of Science ®Google Scholar
• Wakabayashi T, Morimura Y, Miyamoto Y, et al. Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm. 2003;11:277–286
   PubMed Web of Science ®Google Scholar
• Arcinue CA, Ceron OM, Foster CS. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis. J Ocul Pharmacol Ther. 2013 (Epub 8 Jan 2013)
   Google Scholar
• Jaffe GJ, Martin D, Callanan D, et al. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology. 2006;113:1020–1027
   PubMed Web of Science ®Google Scholar
• Saraiya NV, Goldstein DA. Dexamethasone for ocular inflammation. Expert Opin Pharmacother. 2011;12:1127–1131
   PubMed Web of Science ®Google Scholar
• Maetz HM, Kleinstein RN, Federico D, et al. Estimated prevalence of ocular toxoplasmosis and toxocariasis in Alabama. J Infect Dis. 1987;156:414
   PubMed Web of Science ®Google Scholar
• Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. 1992;114:136–144
   PubMed Web of Science ®Google Scholar
• Lim H, Lee SE, Jung BK, et al. Serologic survey of toxoplasmosis in Seoul and Jeju-do, and a brief review of its seroprevalence in Korea. Korean J Parasitol. 2012;50:287–293
   PubMedGoogle Scholar
• Shields JA. Ocular toxocariasis: a review. Surv Ophthalmol. 1984;28:361–381
   PubMed Web of Science ®Google Scholar
• Schantz PM, Weis PE, Pollard ZF, et al. Risk factors for toxocaral ocular larva migrans: a case-control study. Am J Public Health. 1980;70:1269–1272
   PubMed Web of Science ®Google Scholar
• Pivetti-Pezzi P. Ocular toxocariasis. Int J Med Sci. 2009;6:129–130
   PubMed Web of Science ®Google Scholar
• Gillespie SH, Dinning WJ, Voller A, et al. The spectrum of ocular toxocariasis. Eye (Lond). 1993;7:415–418
   PubMedGoogle Scholar
• Park HY, Lee SU, Huh S, et al. A seroepidemiological survey for toxocariasis in apparently healthy residents in Gangwon-do, Korea. Korean J Parasitol. 2002;40:113–117
   PubMedGoogle Scholar
• de Visser L, Rothova A, de Boer JH, et al. Diagnosis of ocular toxocariasis by establishing intraocular antibody production. Am J Ophthalmol. 2008;145:369–374
   PubMed Web of Science ®Google Scholar
• Glickman LT, Magnaval JF, Domanski LM, et al. Visceral larva migrans in French adults: a new disease syndrome? Am J Epidemiol. 1987;125:1019–1034
   PubMed Web of Science ®Google Scholar
• Taylor MR, Keane CT, O'Connor P, et al. The expanded spectrum of toxocaral disease. Lancet. 1988;1:692–695
   PubMedGoogle Scholar
• Garza-Leon M, Garcia LA. Ocular toxoplasmosis: clinical characteristics in pediatric patients. Ocul Immunol Inflamm. 2012;20:130–138
   PubMed Web of Science ®Google Scholar
• Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003;16:265–272
   PubMed Web of Science ®Google Scholar
• Pawlowski Z. Toxocariasis in humans: clinical expression and treatment dilemma. J Helminthol. 2001;75:299–305
   PubMed Web of Science ®Google Scholar
• Yokoi K, Goto H, Sakai J, et al. Clinical features of ocular toxocariasis in Japan. Ocul Immunol Inflamm. 2003;11:269–275
   PubMed Web of Science ®Google Scholar